N-[4-hydroxyphenyl] retinamide in rheumatoid arthritis: A pilot study

Arthritis and Rheumatism

Volumn 39, Issue 6, 1996, Pages 1021-1026

  Gravallese, Ellen M ^c   Handel, Malcolm L ^a,c   Coblyn, Jonathan ^c   Anderson, Ronald J ^c   Sperling, Richard I ^c   Karlson, Elizabeth W ^c   Maier, Agnes ^c   Ruderman, Eric M ^b,c   Formelli, Franca ^d   Weinblatt, Michael E ^c  

^a ST VINCENT S HOSPITAL   (Australia)

^b RUSH UNIVERSITY   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; COLLAGENASE; FENRETINIDE; STROMELYSIN;

ADULT; ARTICLE; BIOPSY; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIUM; TREATMENT FAILURE;

ANTINEOPLASTIC AGENTS; ARTHRITIS, RHEUMATOID; COLLAGENASES; DRUG ADMINISTRATION SCHEDULE; FEMALE; FENRETINIDE; HUMANS; MATRIX METALLOPROTEINASE 3; METALLOENDOPEPTIDASES; MIDDLE AGED; PILOT PROJECTS; RNA, MESSENGER; SYNOVIAL MEMBRANE; TREATMENT OUTCOME;

EID: 15844408450     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780390620     Document Type: Article

References (32)

1. Decensi A, Bruno S, Giaretti W, Torrisi R, Curotto A, Gatteschi B, Geido E, Polizzi A, Costantini M, Bruzzi P, Nicolò G, Costa A, Boccardo F, Giuliani L, Santi L: Activity of 4-HPR in superficial bladder cancer using DNA flow cytometry as an intermediate endpoint. J Cell Biochem Suppl 161:139-147, 1992
2. Marth C, Bock G, Daxenbichler G: Effect of 4-hydroxyphenyl-retinamide and retinoic acid on proliferation and cell cycle of cultured human breast cancer cells. J Natl Cancer Inst 75:871-875, 1985
3. Welsch CW, DeHoog JV, Moon RC: Inhibition of mammary tumorigenesis in nulliparous C3H mice by chronic feeding of the synthetic retinoid, N-(4-hydroxyphenyl)-retinamide. Carcinogenesis 4:1185-1187, 1983
4. Harris ED Jr: Retinoid therapy for rheumatoid arthritis. Ann Intern Med 100:146-147, 1984
5. Haraoui B, Wilder RL, Allen JB, Sporn MB, Helfgott RK, Brinckerhoff CE: Dose-dependent suppression by the synthetic retinoid, 4-hydroxyphenyl retinamide, of streptococcal cell wall-induced arthritis in rats. Int J Immunopharmacol 7:903-916, 1985
6. Yocum DE, Lafyatis R, Remmers EF, Schumacher HR, Wilder RL: Hyperplastic synoviocytes from rats with streptococcal cell wall-induced arthritis exhibit a transformed phenotype that is thymic-dependent and retinoid inhibitable. Am J Pathol 132:38-48, 1988
7. Brinckerhoff CE, Coffey JW, Sullivan AC: Inflammation and collagenase production in rats with adjuvant arthritis reduced with 13-cis-retinoic acid. Science 221:756-758, 1983
8. Klinkhoff AV, Gertner E, Chalmers A, Gladman DD, Stewart WD, Schachter GD, Schachter RK: Pilot study of etretinate in psoriatic arthritis. J Rheumatol 16:789-791, 1989
9. Hopkins R, Bird HA, Jones H, Hill J, Surrall KE, Astbury C, Miller A, Wright V: A double-blind controlled trial of etretinate (Tigason) and ibuprofen in psoriatic arthritis. Ann Rheum Dis 44:189-193, 1985
10. Lassus A, Eskelinen A, Saila K, Koenoenen M, Lauharanta J: Treatment of Reiter's disease with etretinate. In, Retinoids: New Trends in Research and Therapy. Edited by JH Saurat. New York, Karger, 1985
11. Bird HA, Hill J, Sitton NG, Dixon JS, Wright V: A clinical and biochemical evaluation of etretinate in rheumatoid arthritis. Rheumatol Int 8:55-59, 1988
12. Brinckerhoff CE, McMillan RM, Dayer J-M, Harris ED Jr: Inhibition by retinoic acid of collagenase production in rheumatoid synovial cells. N Engl J Med 303:432-436, 1980
13. Brinckerhoff CE, Auble DT: Regulation of collagenase gene expression in synovial fibroblasts. Ann N Y Acad Sci 580:355-374, 1990
14. Nicholson RC, Mader S, Nagpal S, Leid M, Rochette-Egly C, Chambon P: Negative regulation of the rat stromelysin gene promoter by retinoic acid is mediated by an API binding site. EMBO J 9:4443-4454, 1990
15. Lafyatis R, Kim SJ, Angel P, Roberts AB, Sporn MB, Karin M, Wilder RL: Interleukin-1 stimulates and all-trans-retinoic acid inhibits collagenase gene expression through its 5′ activator protein-1-binding site. Mol Endocrinol 4:973-980, 1990
16. Pan L, Brinckerhoff CE: Inhibition of collagenase gene expression in synovial fibroblasts by all-trans and 9-cis retinoic acid. Ann N Y Acad Sci 732:335-347, 1994
17. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA Jr, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315-324, 1988
18. Formelli F, Clerici M, Campa T, Gaetana Di Mauro M, Magni A, Mascotti G, Moglia D, De Palo G, Costa A, Veronesi U: Five-year administration of fenretinide: pharmacokinetics and effects on plasma retinol concentrations. J Clin Oncol 11:2036-2042, 1993
19. Formelli F, Carsana R, Costa A, Buranelli F, Campa T, Dossena G, Magni A, Pizzichetta M: Plasma retinol level reduction by the synthetic retinoid fenretinide: a one year follow-up study of breast cancer patients. Cancer Res 49:6149-6152, 1989
20. Paulus HE, Egger MJ, Ward JR, Williams HJ, and the Cooperative Systematic Studies of Rheumatic Diseases Group: Analysis of improvement in individual rheumatoid arthritis patients treated with disease-modifying antirheumatic drugs, based on the findings in patients treated with placebo. Arthritis Rheum 33:477-484, 1990
21. Gravallese EM, Darling JM, Ladd AL, Katz JN, Glimcher LH: In situ hybridization studies of stromelysin and collagenase messenger RNA expression in rheumatoid synovium. Arthritis Rheum 34:1076-1084, 1991
22. Rich BE, Steitz JA: Human acidic ribosomal phosphoproteins P0, P1 and P2: analysis of cDNA clones, in vitro synthesis, and assembly. Mol Cell Biol 7:4065-4074, 1987
23. Darling JM, Glimcher LH, Shortkroff S, Albano B, Gravallese EM: Expression of metalloproteinases in pigmented villonodular synovitis. Hum Pathol 25:825-830, 1994
24. Rotmensz N, De Palo G, Formelli F, Costa A, Marubini E, Campa T, Crippa A, Danesini GM, Delle Grottaglie M, Di Mauro MG, Filiberti A, Gallazzi M, Guzzon A, Magni A, Malone W, Mariani L, Palvarini M, Perloff M, Pizzichetta M, Veronesi U: Long-term tolerability of fenrelinide (4-HPR) in breast cancer patients. Eur J Cancer 27:1127-1131, 1991
25. Trentham DE, Brinckerhoff CE: Augmentation of collagen arthritis by synthetic analogues of retinoic acid. J Immunol 129:2668-2672, 1982
26. Villa ML, Ferrario E, Trabattoni D, Formelli F, DePalo G, Magni A, Veronesi U, Clerici E: Retinoids, breast cancer and NK cells. Br J Cancer 68:845-850, 1993
27. Trechsel U, Evêquoz V, Fleisch H: Stimulation of interleukin 1 and 3 production by retinoic acid in vitro. Biochem J 230:339-344, 1985
28. Auble DT, Brinckerhoff CE: The AP-1 sequence is necessary but not sufficient for phorbol induction of collagenase in fibroblasts. Biochemistry 30:4629-4635, 1991
29. Petkovich M, Brand NJ, Krust A, Chambon P: A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature 330:444-450, 1987
30. Leid M, Kastner P, Lyons R, Nakshatri H, Saunders M, Zacharewski T, Chen JY, Staub A, Garnier JM, Mader S, Chambon P: Purification, cloning and RXR identity of the HeLa cell factor which RAR or TR heterodimerizes to bind target sequences efficiently. Cell 68:377-395, 1992
31. Mangelsdorf DJ, Borgmeyer U, Heyman RA, Zhou JY, Ong ES, Oro AE, Kakizuka A, Evans RM: Characterization of three RXR genes that mediate the action of 9-cis retinoic acid. Genes Dev 6:329-344, 1992
32. Clark SD, Kobayashi DK, Welgus HG: Regulation of the expression of tissue inhibitor of metalloproteinases and collagenase by retinoids and glucocorticoids in human fibroblasts. J Clin Invest 80:1280-1288, 1987